Skip to main content

and
  1. Article

    Editorial

    Stefan Chłopicki in Pharmacological Reports (2009)

  2. No Access

    Article

    Anti-diabetic effects of 1-methylnicotinamide (MNA) in streptozocin-induced diabetes in rats

    1-Methylnicotinamide (MNA), a major endogenous metabolite of nicotinamide, possesses anti-thrombotic and anti-inflammatory activity, and reverses endothelial dysfunction. In the present work, we investigated w...

    Cezary Watała, Piotr Kaźmierczak, Marcin Dobaczewski in Pharmacological Reports (2009)

  3. No Access

    Article

    Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis

    Nicotinamide N-methyltrasferase (NMMT) catalyzes the conversion of nicotinamide (NA) to 1-methylnicotinamide (MNA). Recent studies have reported that exogenous MNA exerts anti-thrombotic and anti-inflammatory ...

    Łukasz Mateuszuk, Tamara I. Khomich, Ewa Słomińska in Pharmacological Reports (2009)

  4. Article

    Editorial

    Stefan Chłopicki in Pharmacological Reports (2010)

  5. No Access

    Article

    Endurance training increases exercise-induced prostacyclin release in young, healthy men — relationship with VO2max

    In the present study, we evaluated the effect of 5 weeks of moderate-intensity endurance training on the basal and exercise-induced systemic release of prostacyclin (PGI2), as assessed by plasma 6-keto-PGF conc...

    Jerzy A. Zoladz, Joanna Majerczak, Krzysztof Duda in Pharmacological Reports (2010)

  6. No Access

    Article

    Endothelium — therapeutic target in stroke and neurodegenerative disorders

    Ryszard T. Smoleński, Przemysław Kowiański, Monika Waśkow in Pharmacological Reports (2011)

  7. No Access

    Article

    Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6

    Methylnicotinamide (MNA) displays vasoprotective activity, however, the regulation of the activity of nicotinamide- N-methyltransferase (NNMT), is largely unknown. We analyze a possible involvement of IL-6 in ...

    Stefan Chłopicki, Marta Kurdziel, Magdalena Sternak in Pharmacological Reports (2012)

  8. Article

    Antithrombotic effect of novel N-methynicotinamide-like structure (C2507)

    Karol Kramkowski, Agnieszka Leszczyńska, Kamil Przyborowski in Pharmacological Reports (2013)

  9. Article

    Antithrombotic effects of pyridinium compounds present in coffee beans

    Bartłomiej Kałaska, Agnieszka Leszczyńska, Karol Kramkowski in Pharmacological Reports (2013)

  10. No Access

    Article

    Different effects of nitrate and nitrite on hemostasis in rats

    Karol Kramkowski, Agnieszka Leszczyńska, Kamil Przyborowski in Pharmacological Reports (2013)

  11. No Access

    Article

    Narrow time window of metabolic changes associated with transition to overt heart failure in Tgaq*44 mice

    The timing and consequences of alternations in substrate utilization in heart failure (HF) and their relationship with structural changes remain unclear. This study aimed to analyze metabolic changes associate...

    Elżbieta Czarnowska, Joanna B. Bierła, Marta Toczek in Pharmacological Reports (2016)

  12. Article

    Open Access

    Platelets in COVID-19 disease: friend, foe, or both?

    Immuno-thrombosis of COVID-19 results in the activation of platelets and coagulopathy. Antiplatelet therapy has been widely used in COVID-19 patients to prevent thrombotic events. However, recent analysis of c...

    Marta Smęda, Ebrahim Hosseinzadeh Maleki, Agnieszka Pełesz in Pharmacological Reports (2022)